Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Blueberry anthocyanin supplementation shows favorable trends in glycemic control and alters the gut microbiota in type 2 diabetes patients: a pilot study.

  • 2026
  • Food & function 17(8)
    • Xindi Hu
    • Lujing Xu
    • Ying Li
    • Xingyu Zhao
    • Yakun Xing
    • Jin Feng
    • Jiawei Zheng
    • Cheng Xue
    • Wuyang Huang
    • Wuyang Huang
    • Shan Lu

Study Design

Type
Clinical Trial
Population
15 elderly T2DM patients
Methods
6-month pilot study; 15 T2DM patients received 400 mg/day BAE (n=8) or no supplement (n=7); assessments at baseline, 1, 3, and 6 months
Duration
6 months
  • Rigorous Journal
Growing evidence supports the hypoglycemic potential of blueberry anthocyanins, though clinical data remain limited. This study aimed to evaluate the effects of blueberry anthocyanin extract (BAE) supplementation on glycemic control and gut microbiota composition in patients with type 2 diabetes mellitus (T2DM). This 6-month pilot study included 15 elderly T2DM patients, who received either 400 mg day-1 BAE (n = 8) or no supplement (n = 7). Glycemic parameters, gut microbiota (analyzed via 16S rRNA sequencing), and fecal short-chain fatty acids (SCFAs) were assessed at the baseline and after 1, 3, and 6 months. While statistically significant improvements in glycemic parameters were not achieved, favorable trends in fasting glucose and HbA1c were observed upon BAE intervention. Notably, BAE supplementation significantly altered gut microbiota composition by reducing the relative abundance of Firmicutes and increasing Bacteroidota (P < 0.05) and elevated SCFA levels, though the latter change was not statistically significant. Correlation analysis further revealed associations between specific bacterial genera, glucose metabolism indicators, and SCFAs. These findings suggest that BAE may modulate the gut microbiota and improve glucose metabolism in T2DM, supporting its potential as a dietary adjunct for glycemic management, although larger trials are needed for confirmation.

Research Insights

Back to top